Clovis Oncology
FDA Grants New Indication for Rubraca
The FDA granted a new indication for Rubraca for the maintenance treatment of recurrent ovarian, fallopian tube or ...
APRIL 6, 2018
Rucaparib Receives Priority Review for Advanced Mutant BRCA Ovarian Cancer
The therapy is being developed as monotherapy treatment of advanced ovarian cancer in patients with deleterious ...
AUGUST 24, 2016
Load more